Bolignano, D.; Greco, M.; Arcidiacono, V.; Presta, P.; Caglioti, A.; Andreucci, M.; Dragone, F.; Foti, D.P.; Coppolino, G.
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy. Medicina 2022, 58, 890.
https://doi.org/10.3390/medicina58070890
AMA Style
Bolignano D, Greco M, Arcidiacono V, Presta P, Caglioti A, Andreucci M, Dragone F, Foti DP, Coppolino G.
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy. Medicina. 2022; 58(7):890.
https://doi.org/10.3390/medicina58070890
Chicago/Turabian Style
Bolignano, Davide, Marta Greco, Valentina Arcidiacono, Pierangela Presta, Alfredo Caglioti, Michele Andreucci, Francesco Dragone, Daniela Patrizia Foti, and Giuseppe Coppolino.
2022. "Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy" Medicina 58, no. 7: 890.
https://doi.org/10.3390/medicina58070890
APA Style
Bolignano, D., Greco, M., Arcidiacono, V., Presta, P., Caglioti, A., Andreucci, M., Dragone, F., Foti, D. P., & Coppolino, G.
(2022). Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy. Medicina, 58(7), 890.
https://doi.org/10.3390/medicina58070890
